Vbi Vaccines Inc CS (NQ: VBIV )
0.6300
+0.0351
(+5.90%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Vbi Vaccines Inc CS
![](https://cdn.benzinga.com/files/images/story/2023/04/06/seachange_international_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/bullfrog_ai_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/11.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/vbiv.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Looking Into VBI Vaccines's Return On Capital Employed
December 20, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20230404005433/en/1755205/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5379.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/12/aapharma_8.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20230313005265/en/1736320/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines Reports Full Year 2022 Financial Results
March 13, 2023
From VBI Vaccines Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230223005358/en/1721022/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines to Discuss Progress in Hepatitis B Portfolio in Analyst-Led Fireside Chat
February 23, 2023
From VBI Vaccines Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230215005229/en/1713942/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/18/image_6.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_24268.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221208005177/en/1658664/5/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23992.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23059.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221206005302/en/1655845/4/CEPI_Logo.jpg)
From VBI Vaccines Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221122005244/en/1644688/5/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22772.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221114005275/en/1635059/5/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines to Participate in Upcoming Investor Conferences
November 14, 2022
From VBI Vaccines Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7445.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022
November 11, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221111005095/en/1633817/5/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20221110005335/en/1632295/5/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20221017005335/en/1603310/5/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20221012005396/en/1599370/5/Agenus_Logo.jpg)
![](https://ml.globenewswire.com/media/4e129429-cd74-4525-86ce-3c3df41cca83/small/agenus-inc-logo.jpg)
![](https://mms.businesswire.com/media/20220929005213/en/1586523/5/VBI_Vaccines_Logo_Horiz_RGB.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.